; GAO study on gaps in Medicaid coverage for pregnant and postpartum women with substance use disorder. Sec. 1007. Medicaid health homes for opioid-use-disorder Medicaid enrollees. Title II—Medicare Provisions to Address the Opioid Crisis Sec. 2001. Authority not to apply certain Medicare telehealth requirements in the case of certain treatment of a substance use disorder or co-occurring mental health disorder. Sec. 2002. Encouraging the use of non-opioid analgesics for the management of post-surgical pain. Sec. 2003. Requiring a review of current opioid prescriptions for chronic pain and screening for opioid use disorder to be included in the Welcome to Medicare initial preventive physical examination. Sec. 2004. Modification of payment for certain outpatient surgical services. Sec. 2005. Requiring e-prescribing for coverage of covered part D controlled substances. Sec. 2006. Requiring prescription drug plan sponsors under Medicare to establish drug management programs for at-risk beneficiaries. Sec. 2007. Medicare coverage of certain services furnished by opioid treatment programs. Title III—Other Health Provisions to Address the Opioid Crisis Sec. 3001. Clarifying FDA regulation of non-addictive pain and addiction therapies. Sec. 3002. Surveillance and Testing of Opioids to Prevent Fentanyl Deaths. Sec. 3003. Allowing for more flexibility with respect to medication-assisted treatment for opioid use disorders. Sec. 3004. High-quality, evidence-based opioid analgesic prescribing guidelines and report. Sec. 3005. Report on opioids prescribing practices for pregnant women. Sec. 3006. Guidelines for prescribing naloxone. Sec. 3007. Requiring a survey of substance use disorder treatment providers receiving Federal funding. Title IV—Offsets Sec. 4001. Promoting value in Medicaid managed care. Sec. 4002. Extending period of application of Medicare secondary payer rules for individuals with end stage renal disease. Sec. 4003. Requiring reporting by group health plans of prescription drug coverage information for